BPIQ Blog

$XBI $131.63 -0.30% Covid Updates $NVAX +2.9% Novavax Statement on CDC Guidance Update for COVID-19 Clinical Trial Participants source...

$XBI $132 +3% Pipeline Updates $ATXI -2% Received an Appeal Denied Letter from the Office of Neuroscience of the FDA in response to their...

$XBI $128.58 -0.45% Covid Updates $SRNE -3.0% Sorrento Exercises Exclusive Option Agreement With Texas A&M University for MPRO...

$XBI $129.16 +1.1% Covid Updates $BNTX +2.1% Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License...

$XBI $127.75 +/-0.0% Covid Updates $SRNE +1.9% Sorrento Therapeutics Announces Entry Into Option Agreement to Exclusively License MPRO...

$XBI $127.74 +4.6% Covid Updates $BNTX +9.6% Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals...

$XBI $122 +3% Covid Updates $AZN +1% AZD7442 PROVENT Phase III prophylaxis trial met primary endpoint in preventing COVID-19. source...

$XBI $118.69 -2.4% Covid Updates $SRNE -1.8% Sorrento Announces Its Lead Protein-Based COVID-19 Vaccine Candidate – DYAI-100 – Elicits...

$XBI $122 -2% Pipeline Updates $LQDA -2% No Form 483 observations were issued during 5-day inspection. source $PRTK +1% Announces FDA...

$XBI $123.70 +1.57% Covid Updates $GRTS +8.5% Gritstone and CEPI Announce Agreement to Advance Second-Generation COVID-19 Vaccine...

$XBI $121.79 -2.30% Covid Updates $BNTX -9.0% Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster...

$XBI $125 -2% Pipeline Updates $SESN -75% Sesen Bio Receives Complete Response Letter from FDA for Vicineum™ (oportuzumab monatox-qqrs)....

$XBI $126.79 +0.9% Pipeline Updates $FUSN +1.2% Fusion Pharmaceuticals and TRIUMF Announce Expanded R&D Collaboration for Actinium...

$XBI $125.66 -0.70% Covid Updates $SRNE +0.70% Sorrento and Dyadic Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine...

$XBI $126.48 -0.81% Pipeline Updates $ADMA -0.7% ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in...

$XBI $127.53 +0.20% COVID Updates $SRNE +4.2% Sorrento Unveils Overview of Its MultiValent mRNA COVID-19 Vaccine Development Program...

$XBI $127.29 -2% Pipeline Updates $SPPI -21.5% Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS®...

$XBI $125.54 +3.8% Covid Updates $NVAX +5.5% Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in...

$XBI $124.82 +0.7% Covid Updates $SRNE -1.8% Sorrento Mexico and the National Institute of Genomic Medicine (INMEGEN) of Mexico...

$XBI $123.93 +0.40% Covid Updates $ARCT +10.75% Arcturus Announces Approval of a Clinical Trial Application to Advance ARCT-154, a...